1 finantziazioak - 206.250€

2023az geroztik eskuragarri dauden datuak

2023

  1. DEVELOPMENT OF ADENO ASSOCIATED VECTORS FOR IN VIVO RENAL GENE THERAPY: TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE TYPE II

    euro 206.250,00